These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 660339)

  • 41. Treatment of diabetes insipidus with carbamazepine.
    Wales JK
    Lancet; 1975 Nov; 2(7942):948-51. PubMed ID: 53432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM; Lumpkin HL
    Obstet Gynecol; 1986 Nov; 68(5):726-8. PubMed ID: 3763091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of diabetes insipidus].
    Boscaro M; Mani E; Pistorello M; Rampazzo A
    Minerva Endocrinol; 1990; 15(1):95-9. PubMed ID: 2274021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of central diabetes insipidus.
    Garrahy A; Thompson CJ
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of central diabetes insipidus with DDAVP.
    Chiu WT; Shih CJ; Chen HY; Lin LS
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):944-52. PubMed ID: 3865998
    [No Abstract]   [Full Text] [Related]  

  • 49. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period.
    Burrow GN; Wassenaar W; Robertson GL; Sehl H
    Acta Endocrinol (Copenh); 1981 May; 97(1):23-5. PubMed ID: 7223315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
    Radó JP
    Am J Med Sci; 1978; 275(1):43-52. PubMed ID: 665711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
    Kinter LB; Beeuwkes R
    Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral desmopressin treatment of central diabetes insipidus in children.
    Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
    Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?
    Broadbent V; Pritchard J
    Med Pediatr Oncol; 1997 Apr; 28(4):289-93. PubMed ID: 9078326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morbidity and mortality associated with vasopressin replacement therapy in children.
    Rizzo V; Albanese A; Stanhope R
    J Pediatr Endocrinol Metab; 2001; 14(7):861-7. PubMed ID: 11515726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM
    Obstet Gynecol; 1986 Aug; 68(2):288-9. PubMed ID: 3737046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paradoxical diuresis after vasopressin administration to patients with neurohypophyseal diabetes insipidus treated with chlorpropamide, carbamazepine or clofibrate.
    Meinders AE; van Leeuwen AM; Borst JG; Cejka V
    Clin Sci Mol Med; 1975 Oct; 49(4):283-90. PubMed ID: 1192687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differing responses of cortisol to oCRF during endonasal and oral treatment with DDAVP.
    Carraro A; Giusti M; Porcella E; Sessarego P; Giordano G
    Eur J Clin Invest; 1994 Jul; 24(7):459-62. PubMed ID: 7957502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies of a new synthetic vasopressin derivative (DDAVP) in man].
    Radó J; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Orv Hetil; 1976 Mar; 117(13):775-8. PubMed ID: 768869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.